A functional screen for regulators of CKDN2A reveals MEOX2 as a transcriptional activator of INK4a

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Irelan, Jeffrey T ^a   del Arroyo, Ana Gutierrez ^b,f   Gutierrez, Abel ^a,d   Peters, Gordon ^b   Quon, Kim C ^a,e   Miraglia, Loren ^a   Chanda, Sumit K ^a,c  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^b CRUK London Research Institute   (United Kingdom)

^c BURNHAM INSTITUTE   (United States)

^d V and P Scientific Inc   (United States)

^e AMGEN INC   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4A; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MEOX2; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; MEOX2 PROTEIN, HUMAN; PRIMER DNA; TRANSACTIVATOR PROTEIN;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE LOCUS; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC SCREENING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NEWBORN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE; TRANSCRIPTION REGULATION; CELL CULTURE; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PRIMERS; DNA, COMPLEMENTARY; HOMEODOMAIN PROTEINS; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 64549140317     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005067     Document Type: Article

References (22)

1. Ruas M, Peters G (1998) The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochimica et Biophysica Acta 1378: F115-177.
2. Sherr CJ (2001) Parsing Ink4a/Arf: "pure" p16-null mice. Cell 106: 531-534.
3. Sherr CJ (2001) The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2: 731-737.
4. Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nature Reviews Molecular Cell Biology 8: 729-740.
5. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, et al. (2001) Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409: 1067-1070.
6. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, et al. (2005) Tumour biology: senescence in premalignant tumours.[see comment]. Nature 436: 642.
7. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi.[see comment]. Nature 436: 720-724.
8. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, et al. (2005) Oncogene-induced senescence as an initial barrier in lymphoma development.[- see comment]. Nature 436: 660-665.
9. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. [see comment]. Nature 436: 725-730.
10. Pardal R, Molofsky AV, He S, Morrison SJ (2005) Stem cell self-renewal and cancer cell proliferation are regulated by common networks that balance the activation of proto-oncogenes and tumor suppressors. Cold Spring Harb Symp Quant Biol 70: 177-185.
11. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R (2005) Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19: 1432-1437.
12. Bruggeman SW, Valk-Lingbeek ME, van der Stoop PP, Jacobs JJ, Kieboom K, et al. (2005) Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev 19: 1438-1443.
13. Wang W, Wu J, Zhang Z, Tong T (2001) Characterization of regulatory elements on the promoter region of p16(INK4a) that contribute to overexpression of p16 in senescent fibroblasts. J Biol Chem 276: 48655-48661.
14. Park YB, Park MJ, Kimura K, Shimizu K, Lee SH, et al. (2002) Alterations in the INK4a/ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet Cytogenet 133: 105-111.
15. Owens BM, Hawley RG (2002) HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells 20: 364-379.
16. Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, et al. (1997) p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev 11: 1674-1689.
17. Gorski DH, LePage DF, Patel CV, Copeland NG, Jenkins NA, et al. (1993) Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells. Mol Cell Biol 13: 3722-3733.
18. Chen Y, Leal AD, Patel S, Gorski DH (2007) The homeobox gene GAX activates p21WAF1/CIP1 expression in vascular endothelial cells through direct interaction with upstream AT-rich sequences. Journal of Biological Chemistry 282: 507-517.
19. Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, et al. (2002) INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. Embo J 21: 2936-2945.
20. Mankoo BS, Skuntz S, Harrigan I, Grigorieva E, Candia A, et al. (2003) The concerted action of Meox homeobox genes is required upstream of genetic pathways essential for the formation, patterning and differentiation of somites. Development 130: 4655-4664.
21. Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, et al. (2005) Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease.[see comment]. Nature Medicine 11: 959-965.
22. Cortese R, Hartmann O, Berlin K, Eckhardt F (2008) Correlative gene expression and DNA methylation profiling in lung development nominate new biomarkers in lung cancer. International Journal of Biochemistry & Cell Biology 40: 1494-1508.